Zimbabwe has turned down a significant US health deal worth $367m (£272m) over five years because of Washington's insistence on sensitive biological samples.
This move was revealed after a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
A government representative has since clarified that the US was seeking biological samples for research and commercial purposes but was unwilling to guarantee the benefits from future treatments.
"We will now turn to the challenging and unfortunate process of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had donated over $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged further negotiations to find a deal agreeable to both sides so the country's vital HIV programme can proceed.
Broader Background
This rejection comes after a comparable situation in neighbouring Kenya, where a court blocked a similar deal with the US after legal challenges were filed about the safety of citizens' health data.
Since resuming the presidency last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had managed aid for the US government, but Trump claimed its spending was "wasteful" and his government was seeking direct bilateral deals to boost openness and accountability.
Based on statements, 16 nations in Africa have so far agreed to these new health pacts, constituting more than $18.3bn in new funding.
Details of the Rejected Deal
The money for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation would have delivered significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through US-supported programmes," Tremont said.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, without any equivalent guarantee of access to any medical innovations – like new medicines or tests – that could result from that provided information," he stated.
"In essence, our country would provide the raw materials for scientific discovery with no assurance that the end products would be accessible to our population should a new pandemic arise."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures previously set up through the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to deal with potential global health emergencies.
"This system is designed to guarantee that when a nation provides its data, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," he added.
"We encourage continued discussions with our US partners on how subsequent collaboration could be designed in a manner that respects the independence and interests of each country."
Health Experts Response
Medical experts expressed it acknowledged the government's concerns, but recommended that negotiations should continue considering much of the country's HIV programmes relied on external financing.
"Where technical issues exist, such as those relating to data governance or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," it added.
The situation underscores the ongoing tensions between accepting vital foreign assistance and safeguarding local interests in an increasingly interconnected world.